◆ The restructuring of NINGKE Biotechnology
After a series of twists and turns, NINGKE finally obtained its third road permit in 2025, which undoubtedly brings it a new turning point. However, this year’s restructuring shares have yet to demonstrate strong momentum, largely due to the previous poor performance of Sansheng Zhongzhuang’s stock price.
Hunan ChunTou Industrial Development Co., Ltd., as the investor in NINGKE Industry, will gain actual control over the company after the completion of its restructuring proceedings. The subscription price for this industrial investment is 1.12 yuan per share, and a lock-up period of 36 months has been committed.
◆ Hunan ChunTou’s Equity Investment and Prospects
The subscription price for the equity investment is 1.6 yuan per share, and it is committed that, upon expiration of the lock-up period—12 months—the shares can be freely transferred.
The reorganized total share capital stands at 1.6 billion shares, and we look forward to its outstanding performance, setting a positive example for reorganized stocks.
Investor Relations Hotline: 86 0952-3671243 Sales Customer Service Hotline: 86 0952-7887168
-
Service Email
-
Customer service phone
Service Email:
Customer service phone:
导航下拉添加类名.active
页面顺滑的滚动
启用全局默认滚动动画 (向上滚动)
右侧在线客服样式 1,2,3 1
图片alt标题设置: NINGKE
表单验证提示文本: Content cannot be empty!
循环体没有内容时: Sorry,no matching items were found.
CSS / JS 文件放置地